Eur Rev Med Pharmacol Sci 2012; 16 (9): 1137-1154 Role of fatty acids and polyphenols in inflammatory gene transcription and their impact on obesity, metabolic syndrome and diabetes B. Sears, C. Ricordi*
Eur Rev Med Pharmacol Sci 2012; 16 (5): 617-621 Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus Z. Ariturk, Y. Islamoglu, H. Cil, E. Tekbas, S. Soydinc, H. Kaya, M.A. Elbey
Eur Rev Med Pharmacol Sci 2012; 16 (3 Suppl): 18-27 Antihyperglycemic and protective effects of Trigonella foenum graecum seed powder on biochemical alterations in alloxan diabetic rats P. Kumar, R.K. Kale, N.Z. Baquer
Eur Rev Med Pharmacol Sci 2012; 16 (3 Suppl): 10-17 Effect of Trigonella foenum-graecum seed powder on the antioxidant levels of high fat diet and low dose streptozotocin induced type II diabetic rats P. Sankar, S. Subhashree, S. Sudharani
Eur Rev Med Pharmacol Sci 2012; 16 (1): 57-65 Antioxidant, antiglycation and inhibitory potential of Saraca ashoka flowers against the enzymes linked to type 2 Diabetes and LDL oxidation A. Prathapan, Suresh V. Nampoothiri, S. Mini*, K.G. Raghu
Eur Rev Med Pharmacol Sci 2011; 15 (11): 1306-1310 A hospital based study of prevalence of gestational diabetes mellitus in an urban population of India M.V. Jali*, B.R. Desai**, S. Gowda#, S. Kambar***, S.M. Jali§
Eur Rev Med Pharmacol Sci 2011; 15 (11): 1256-1263 Hypertension management in diabetic patients Z. Anwer, P.K. Sharma, V.K. Garg, N. Kumar, A. Kumari
Eur Rev Med Pharmacol Sci 2011; 15 (7): 751-758 Diabetes mellitus: biochemical, histological and microbiological aspects in periodontal disease L. Marigo, R. Cerreto, M. Giuliani, F. Somma, C. Lajolo, M. Cordaro
Eur Rev Med Pharmacol Sci 2010; 14 (9): 749-758 Efficacy, tolerability and safety of nebivolol in patients with hypertension and diabetes: a post-marketing surveillance study L.M. Van Bortel
Eur Rev Med Pharmacol Sci 2010; 14 (2): 89-95 Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2 D.A. de Luis, M. Gonzalez Sagrado, R. Aller, O. Izaola, R. Conde, B. de La Fuente
Eur Rev Med Pharmacol Sci 2009; 13 (6): 419-423 Small bowel bacterial overgrowth and type 1 diabetes V. Ojetti, D. Pitocco*, E. Scarpellini, F. Zaccardi, F. Scaldaferri, G. Gigante, G. Gasbarrini, G. Ghirlanda*, A. Gasbarrini
Eur Rev Med Pharmacol Sci 2009; 13 (1): 51-55 Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study D.A. de Luis, R. Conde, R. Aller, O. Izaola, M. González Sagrado, J.L. Perez Castrillón, A. Dueñas, E. Romero
Eur Rev Med Pharmacol Sci 2008; 12 (4): 261-266 A randomized clinical trial with two enteral diabetes-specific supplements in patients with diabetes mellitus type 2: metabolic effects D.A. de Luis, O. Izaola, R. Aller*, L. Cuellar, M.C. Terroba, T. Martin, G. Cabezas, S. Rojo, M. Domingo
Eur Rev Med Pharmacol Sci 2007; 11 (4): 249-255 Multidimensional study on quality of life in children with type 1 diabetes E. Ausili, F. Tabacco, B. Focarelli, L. Padua*#, F. Crea, P. Caliandro*#, C. Pazzaglia*#, G. Marietti, C. Rendeli
Eur Rev Med Pharmacol Sci 2007; 11 (3): 155-163 Advances in biochemical mechanisms of diabetic retinopathy C. Giusti, P. Gargiulo*
Eur Rev Med Pharmacol Sci 2006; 10 (2): 69-74DOI: Psychological stress measure in type 2 diabetes G.M. Trovato, D. Catalano, G.F. Martines, D. Spadaro, D. Di Corrado*, V. Crispi*, G. Garufi, S. Di Nuovo* Free PDF Download
Eur Rev Med Pharmacol Sci 2005; 9 (6): 373-378 TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report A. Migliore, U. Massafra, E. Carloni, C. Padalino, S. Martin Martin*, F. Lasaracina, N. Dibiase, A. Alimonti, M. Granata§
Eur Rev Med Pharmacol Sci 2005; 9 (4): 191-208 Postprandial hyperglycemia and hyperlipidemia-generated glycoxidative stress: its contribution to the pathogenesis of diabetes complications O.R. Rebolledo, S.M. Actis Dato
Eur Rev Med Pharmacol Sci 2002; 6 (2): 27-32 Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus P.A. Tataranni
